Trade Arrowhead Pharma - ARWR CFD

Trading Conditions

• Type: CFD
• Spread: 0.13
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 54.97
• Open: 55.74
• 1-Year Change: 264.08%
• Day's Range: 55.74 - 57.42

What is Arrowhead Pharma (ARWR)?

Arrowhead Pharmaceuticals is a biopharmaceutical company specializing in the discovery and development of RNA interference (RNAi) therapeutics. The company focuses on creating treatments that silence specific genes involved in disease processes, targeting conditions such as genetic disorders, cardiovascular diseases, and liver-related illnesses. Arrowhead utilizes proprietary delivery technologies to enhance the stability and efficacy of its RNAi compounds. Its research and development pipeline includes multiple candidates at various stages of clinical investigation. The company collaborates with academic and industry partners to advance its therapeutic programs. Arrowhead Pharmaceuticals operates within the biotechnology sector, aiming to develop innovative medicines that address the root causes of diseases at the genetic level.

Arrowhead Pharma Stock Price Today: Live Overview

The price today is shaped by Arrowhead Pharma's trading range, sitting at $57.44. Price movement today has covered the range from $54.2 to $57.46, changing by +4.0727%.

FAQ: Arrowhead Pharma (ARWR)

What is the current price of ARWR stock?

The current stock price stands at $57.44.

Does ARWR pay dividends?

Arrowhead Pharma does not pay dividends.

Does ARWR have a formal corporate presence or regional headquarters in the UAE?

Arrowhead Pharma does not have an official regional office or subsidiary in the UAE and operates through partners or distributors.

What is ARWR best known for?

The company is most famous for its RNA interference-based therapeutics.

What assets are typically shown together with ARWR?

Commonly shown alongside ARWR: Celcuity Inc, Paradigm Biopharmaceuticals Limited, Amprius Technologies Inc